Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-26 @ 12:39 AM
Study NCT ID:
NCT03481660
Status:
COMPLETED
Last Update Posted:
2025-01-07
First Post:
2018-03-19
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-27
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-08
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-19
First Submit QC Date:
None
Study First Post Date:
2018-03-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-05-17
Results First Submit QC Date:
None
Results First Post Date:
2024-01-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-06
Last Update Post Date:
2025-01-07
Last Update Post Date Type:
ACTUAL